Clinical Bioinformatics Interview Questions & Answers

← All NHS Healthcare Science interview questions

About this NHS interview question bank

To prepare for a clinical bioinformatics NHS interview, expect questions on validating and change-controlling analysis pipelines, version control and reproducibility, information governance for genomic data, software as a medical device, and how you explain technical problems to clinicians and lab scientists. Prepare short spoken examples from your own pipeline, data or training work, and know the NHS Genomic Medicine Service, ISO 15189 and the NHS values before you walk in.

This bank contains 40 original practice questions with first-person model answers for clinical bioinformaticians applying for Band 6 posts, with a selection pitched at Band 7 clinical scientist level, including Scientist Training Programme (STP) bioinformatics graduates. It covers genomics, health informatics and physical sciences settings, and each answer is built around a realistic, non-identifying scenario such as a pipeline bug found after reporting, a sample swap caught by a QC check or an AI tool that needs validating. Every question explains what the panel is really assessing, the points you must hit, the mistakes to avoid and the frameworks worth reading, so you can practise answers that sound like you rather than a textbook.

 

What this question bank covers

• Motivation for clinical bioinformatics
• NHS values in a non-patient-facing role
• NHS Genomic Medicine Service and Genomic Laboratory Hubs
• Pipeline validation and verification
• Change control and version control
• Reproducibility and containerisation
• Software as a medical device and UK MDR principles
• UKAS ISO 15189 for software
• Information governance and genomic data security
• Communicating with clinicians and lab scientists
• Pipeline bugs, incidents, PSIRF and Duty of Candour
• Sample identity and QC
• Safeguarding in a data role
• Ancestry bias and equity in genomic data
• AI and machine learning validation
• Accessibility of tools
• Leadership at Band 6 and Band 7
• STP, HCPC registration and CPD

 

40 NHS interview questions with full model answers. The first 8 are free to read below. Unlock the remaining 32 for £2.99 (12 months' access).

These are original practice questions written to reflect how NHS interviews are run. They are not leaked or official questions, and Healthcare Interview Prep is independent of the NHS.

 

 

Free NHS interview questions and model answers

 

 

Question 1: Why do you want to work in clinical bioinformatics in the NHS rather than in research or industry?

Motivation question  ·  Motivation

 

What the interview panel is assessing

The panel wants a genuine reason for choosing a clinical service over research or a commercial job. They are listening for an understanding that clinical work means validated, controlled, accountable analysis that affects real diagnoses, and for some realism about the trade-offs.

 

Model answer

For me it came down to what happens to the output. During my MSc project I built a variant filtering workflow, and it was interesting, but when I finished it the results went into a thesis and that was the end of it. Then I spent a few weeks shadowing in a genomics lab, and I watched a clinical scientist sign out a report for a child who had been through years of tests without an answer. The pipeline that produced the candidate variant had been written and validated by the bioinformatics team two floors up. That connection between a line of code and a family finally getting a diagnosis really stayed with me.

I also like the discipline of clinical work. In research you can try a new tool on a Tuesday and use it on Wednesday. In the NHS every change goes through validation, change control and sign-off, because a mistake doesn't just affect a figure in a paper, it can affect someone's treatment or a pregnancy decision. Some people find that slow. I find it reassuring, and I think it's made me a better programmer, because I write tests and documentation as I go rather than as an afterthought.

I'll be honest that industry can pay more, and research can feel more cutting edge. But in the NHS I get to work on real clinical data at scale, alongside clinical scientists, genetic counsellors and consultants, within the Genomic Medicine Service, and I can see the whole path from sample to report. I want to be the person in the team who makes the analysis trustworthy, so that when a scientist reads a result they don't have to wonder whether the software got it right.

 

Why this answer works

The answer is grounded in a specific moment that links code to a patient outcome, which makes it believable. It shows the candidate understands what makes clinical bioinformatics different from research, especially validation and accountability, and it is honest about the trade-offs without sounding negative.

 

Key points to include

• A specific experience that drew you to clinical work
• Understanding that clinical analysis must be validated and controlled
• The link between your code and patient diagnosis or care
• Awareness of the multidisciplinary team you'll work in
• Honest recognition of the trade-offs compared with research or industry

 

Common mistakes to avoid

• Talking only about interesting technology and never mentioning patients
• Criticising research or industry to make the NHS sound better
• Describing the role as a stepping stone to something else
• Sounding frustrated by validation and governance rather than understanding why it exists

 

NHS values and standards

Commitment to quality of care; Improving lives; Working together for patients

 

Further reading

• NHS Constitution for England
• National School of Healthcare Science: Scientist Training Programme overview
• Academy for Healthcare Science: Good Scientific Practice

 

 

Question 2: You won't usually meet patients in this role. How do the NHS values show up in your work?

NHS Values question  ·  NHS Values

 

What the interview panel is assessing

The panel is checking that you know the six NHS values and can connect them to behind-the-scenes scientific work. They want concrete examples of how a bioinformatician's choices affect patients, not a recited list.

 

Model answer

The NHS values are working together for patients, respect and dignity, commitment to quality of care, compassion, improving lives, and everyone counts. It's true I probably won't sit with patients, but every row in the data I work with is somebody waiting for an answer, and I try to keep that in my head.

Commitment to quality of care is the one I live most days. On my STP rotation I was asked to check why a small number of samples had slightly lower coverage over one exon. It would have been easy to say it was within the acceptance criteria and move on. Instead I traced it to a probe design issue, documented it, and the scientists added a note to the reporting template so they knew to consider a confirmatory test for that region. That's quality in my world: not letting something slide because it technically passes.

Respect and dignity shows up in how I treat the data. Genomic data is about as personal as information gets. It can reveal things about a whole family. So I don't copy files to places they don't belong, I don't look at records I don't need, and I talk about cases respectfully, even in a team chat.

Compassion might sound odd for a coder, but it matters when a clinical scientist rings me under pressure because a rapid test for a baby in intensive care is stuck. Being calm, kind and quick in that moment is part of caring for the patient.

And everyone counts reminds me to question whether our tools work equally well for everyone. Reference datasets have historically under-represented some ancestries, and I think it's part of my job to know the limits of what we report.

 

Why this answer works

The answer names all six values accurately and then grounds three or four of them in specific bioinformatics behaviour. It shows the candidate understands their indirect but real impact on patients, and the point about ancestry bias shows depth.

 

Key points to include

• Name the six NHS values accurately
• Link your work clearly to patient outcomes
• A concrete example for at least one value
• Respect for genomic data as deeply personal information
• Awareness of equity and the limits of reference data

 

Common mistakes to avoid

• Saying the values don't really apply because you're not patient-facing
• Listing the values without any example
• Talking only about technical quality and forgetting people
• Using generic examples that could come from any office job

 

NHS values and standards

Working together for patients; Respect and dignity; Commitment to quality of care; Compassion; Improving lives; Everyone counts

 

Further reading

• NHS Constitution for England
• Academy for Healthcare Science: Good Scientific Practice
• HCPC Standards of conduct, performance and ethics

 

 

Question 3: Tell us how you would explain a technical problem with a test to a clinician who has no bioinformatics background.

Communication question  ·  Communication

 

What the interview panel is assessing

The panel wants to see that you can translate technical detail into what it means clinically, without jargon and without overstating or understating the risk. They are also checking that you know when to involve the clinical scientist who owns the report.

 

Model answer

My starting point is always the question the clinician actually cares about: can I trust this result for my patient, and what should I do now? Everything I say has to answer that, not show off how the pipeline works.

I had a version of this during my training. A consultant in a clinical genetics clinic emailed asking why a report said a particular gene had 'incomplete coverage'. She'd been told the test covered that gene and was worried she'd missed something. I first spoke to the clinical scientist who signed the report, because it was her report and I didn't want to give a different message. Then we rang the consultant together.

I explained it with an analogy. I said the test reads the DNA in lots of short overlapping pieces, a bit like reading a book by photocopying random paragraphs many times. For most of the gene we had plenty of copies of every paragraph, so we were confident. For one small section, the copies were thin, so if there was a change there we might not have seen it. I was clear that this didn't mean there was a problem in that section, only that the test couldn't rule one out.

Then the scientist explained the practical options, which included a targeted follow-up test if clinical suspicion for that gene was high. The consultant said that was the first time it had made sense to her. Afterwards I suggested we add a plain-English sentence to the report template explaining what incomplete coverage means, and the scientist took that to the reporting team.

What I've learnt is to avoid words like 'read depth' or 'mapping quality' unless someone asks, check understanding by asking what they'll do next, and never guess about clinical management. That's the clinical scientist's or consultant's call, and my job is to make the technical picture clear and honest.

 

Why this answer works

The answer shows a practical method: start from the clinical question, use a simple analogy, be honest about uncertainty and involve the reporting scientist. It also shows the candidate stays within scope and turns the conversation into a lasting improvement.

 

Key points to include

• Start with what the clinician needs to decide
• Use plain language or a simple analogy
• Be honest about uncertainty without causing alarm
• Involve the clinical scientist who owns the report
• Check understanding and agree next steps
• Stay within your scope on clinical management

 

Common mistakes to avoid

• Burying the clinician in technical terms
• Giving a different message from the authorised report
• Overstating certainty or downplaying a real limitation
• Offering clinical advice that isn't yours to give

 

NHS values and standards

Working together for patients; Commitment to quality of care; Respect and dignity; HCPC Standards: communicate effectively

 

Further reading

• HCPC Standards of proficiency: Clinical scientists
• ACGS Best Practice Guidelines for reporting
• Academy for Healthcare Science: Good Scientific Practice

 

 

Question 4: The wet lab has changed its library preparation kit. How would you work with the lab scientists to make sure the pipeline is still fit for purpose?

Teamwork question  ·  Teamwork

 

What the interview panel is assessing

The panel is testing whether you understand that the pipeline and the wet lab process form one test, and that a change upstream can affect bioinformatics performance. They want to see collaboration, shared planning and respect for change control.

 

Model answer

I'd see this as one test that happens to have two halves, so the first thing is to get round a table with the lab scientists early, ideally before the kit goes live rather than after. I'd want to understand what's actually changed: the capture regions, the fragment size, whether there are new adapters or unique molecular identifiers, and whether the expected coverage profile is different.

On my last rotation something similar happened when the lab moved to a new capture kit with a slightly different target region. Nobody had flagged to us that the BED file had changed. We noticed because the coverage metrics on the first few runs looked odd. Nothing was reported incorrectly, because the QC thresholds caught it, but it was a good lesson. Since then I've been the person who asks at lab meetings whether any upcoming changes might affect the analysis.

For a kit change, I'd agree with the lab lead a joint verification plan under our change control process. On the bioinformatics side, that would mean updating the target files, running a set of samples with known variants, ideally including reference materials and previously reported clinical samples, through both the old and new process, and comparing sensitivity, precision and coverage over clinically important regions. I'd check that the QC thresholds still make sense, because a kit with a different profile might need them reviewed rather than copied across.

I'd write it up with the lab so there's one validation record for the whole test, and the quality manager can see it meets our ISO 15189 requirements. I'd also want the lab scientists to review my summary, because they'll spot wet lab explanations for things I might misread.

Working this way builds trust. The scientists know I'm not going to block their change for the sake of it, and I know they'll tell me before something changes, not after.

 

Why this answer works

This answer treats the test as an end-to-end process and shows the candidate collaborating early. It covers the right technical checks at a sensible level and links the work to change control and accreditation, while showing respect for wet lab expertise.

 

Key points to include

• Treat wet lab and pipeline as one test
• Engage early, before the change goes live
• A joint verification plan under change control
• Test with known samples and review QC thresholds
• A shared validation record that supports ISO 15189

 

Common mistakes to avoid

• Treating it as the lab's problem until something breaks
• Assuming the old thresholds and target files still apply
• Running a few samples and declaring it fine without documented criteria
• Working in isolation without the lab's input on results

 

NHS values and standards

Working together for patients; Commitment to quality of care; HCPC Standards: work in partnership

 

Further reading

• ISO 15189 Medical laboratories: requirements for quality and competence
• ACGS Best Practice Guidelines
• Your laboratory's change control and validation procedures

 

 

Question 5: You discover a bug in the pipeline that may have affected results that have already been reported. What do you do?

Patient Safety question  ·  Patient Safety

 

What the interview panel is assessing

This is a core safety question. The panel wants to see that you act quickly and openly, escalate straight away, protect patients first, avoid fixing things quietly and support a proper investigation including Duty of Candour where it applies.

 

Model answer

The first thing I'd do is stop and make sure I'm not about to make it worse. I wouldn't quietly patch the code in production or rerun anything on my own, because that could destroy the evidence we need to work out who's affected.

I'd escalate immediately to my line manager or the lead clinical scientist, and I'd do it in person or by phone, not just an email that might sit unread. I'd explain what I'd found, how confident I am that it's real, and my early view of which pipeline versions and which types of variant might be affected. If there's any chance live samples are being processed with the same bug, I'd ask whether we should pause reporting from that pipeline while we assess it.

Then I'd help scope the impact properly. Because we use version control and log the pipeline version against every sample, we should be able to list every case run on the affected versions. I'd work with the scientists to re-analyse those samples with a corrected or known-good version in a controlled way and compare outputs, so the clinical team can see exactly which reports change and which don't.

The clinical decisions belong to the clinical scientists and consultants. They'd decide which reports need amending, how urgently, and how to tell referring clinicians. The organisation leads on Duty of Candour where a patient may have been harmed, and the incident would be reported through the trust's system and looked at under PSIRF, which in England focuses on learning rather than blame.

My part is to be completely open about what happened, including if it was my code. I'd write a clear factual account, help fix the bug through proper change control with a test that would have caught it, and think about why our validation missed it. Was there a type of variant we never tested? I'd want that gap closed so it can't happen again.

I won't pretend it wouldn't feel awful. But hiding it or hoping it's minor would be far worse for patients.

 

Why this answer works

The answer prioritises patient safety and evidence preservation, escalates immediately and uses version logs to scope impact. It keeps clinical decisions with the right people, recognises organisational Duty of Candour and PSIRF, and focuses on learning, including honesty about one's own role.

 

Key points to include

• Don't quietly fix it or rerun on your own
• Escalate immediately to the lead scientist or manager
• Consider pausing affected reporting
• Use version records to identify every affected sample
• Clinical teams decide on amended reports; organisation leads Duty of Candour
• Report as an incident and fix through change control with a new test

 

Common mistakes to avoid

• Fixing the bug silently and saying nothing
• Waiting until you're certain before telling anyone
• Contacting clinicians or patients yourself without agreement
• Blaming a colleague or the tool rather than focusing on patients and learning

 

NHS values and standards

Commitment to quality of care; Everyone counts; Working together for patients; HCPC Standards: be open when things go wrong

 

Further reading

• Patient Safety Incident Response Framework (PSIRF)
• Duty of Candour (Regulation 20, Health and Social Care Act 2008 (Regulated Activities) Regulations 2014)
• ISO 15189 requirements on nonconforming work
• HCPC Standards of conduct, performance and ethics

 

 

Question 6: How do you keep genomic data secure and handle it in line with information governance requirements?

Confidentiality question  ·  Confidentiality

 

What the interview panel is assessing

The panel is checking that you understand why genomic data is especially sensitive and that you know the UK legal and NHS framework around it. They want practical, everyday habits, not only the names of laws.

 

Model answer

I start from the fact that genomic data is never really anonymous. Even without a name attached, a genome is unique to a person and tells you things about their relatives too. Under UK GDPR, genetic data is special category data, so it needs extra protection, and the Data Protection Act 2018 and the Caldicott Principles sit on top of that in the NHS.

Day to day, that means a few habits. I only access the data I need for the task in front of me, which is the Caldicott idea of using the minimum necessary. I work within the approved environment, so data stays on the trust's secure servers or the approved high-performance computing system, never on a personal laptop, a USB stick or a personal cloud account. When I test a new tool, I use reference samples or properly approved test data rather than pulling patient data into a sandbox just because it's convenient.

I'm careful with the less obvious things too. Log files, screenshots in a ticket and example outputs pasted into a chat can all contain identifiers. Before sharing anything for troubleshooting, even internally, I strip it back. If I'm asking for help on a public forum about a bug, I'd never include real data.

I'm also clear on the difference between direct care and secondary uses. Using data for the patient's own test is direct care. Using it for research, service evaluation or training a model needs the right legal basis and approvals, and I'd check with the information governance team rather than assume.

If I ever saw data being handled wrongly, or made a mistake myself, like sending a file to the wrong person, I'd report it straight away through the trust's incident process so the IG team can assess it, because there can be a short legal timescale for reporting serious breaches. I complete my mandatory data security training and read the local policies, because they do vary between trusts.

 

Why this answer works

The answer explains why genomic data is special and cites the correct UK framework, then backs it up with realistic daily habits that a bioinformatician would actually practise. It also covers secondary use and breach reporting, which shows a mature understanding.

 

Key points to include

• Genetic data is special category data under UK GDPR
• Caldicott Principles, especially minimum necessary access
• Keep data within approved secure environments
• Watch for identifiers in logs, screenshots and examples
• Distinguish direct care from research and other secondary uses
• Report breaches or near misses promptly

 

Common mistakes to avoid

• Saying genomic data is safe once names are removed
• Listing laws without describing any real behaviour
• Using patient data for testing or development without approval
• Not knowing how to report a data breach

 

NHS values and standards

Respect and dignity; Commitment to quality of care; Caldicott Principles; HCPC Standards: respect confidentiality

 

Further reading

• UK General Data Protection Regulation and Data Protection Act 2018
• The Caldicott Principles
• Data Security and Protection Toolkit
• NHS Records Management Code of Practice
• National Data Guardian guidance

 

 

Question 7: Talk us through how you would validate a new or updated bioinformatics pipeline before it is used clinically.

Technical question  ·  Technical

 

What the interview panel is assessing

The panel wants to know whether you understand validation as a planned, documented, evidence-based process with predefined acceptance criteria. They are looking for appropriate truth sets, relevant performance metrics and sign-off by the right people.

 

Model answer

I'd start before writing any code, with a validation plan. That plan says what the pipeline is intended to do, which variant types and regions it covers, what performance we need and how we'll measure it. Agreeing acceptance criteria in advance matters, because if you decide what counts as good enough after seeing the results, you can talk yourself into anything.

Next is the right truth set. I'd use well-characterised reference materials, such as the Genome in a Bottle samples, alongside previously reported clinical samples with variants confirmed by another method. I'd make sure the set includes the hard cases that matter clinically: indels, variants in repetitive or GC-rich regions, copy number changes if we're calling them, and mosaic variants if the test claims to detect them. A pipeline that's great on simple SNVs and poor on indels isn't validated for indels.

Then I'd measure sensitivity, precision, and repeatability and reproducibility, so the same sample gives the same answer across runs and across operators where that applies. I'd also look at limit of detection where it's relevant, and at coverage over the clinically reportable regions, not just genome-wide averages. Every result would be tied to an exact version of the code, the containers, the reference genome and the annotation databases.

If it's an update rather than a new pipeline, the extent of the work depends on the change. A documentation tweak needs very little, but a new variant caller needs something close to full validation. I'd do a risk assessment to decide that, and I'd always run regression tests to show nothing else has broken.

Finally I'd write a validation report showing the results against the acceptance criteria, any limitations, and how those will be communicated in reports. That gets reviewed and signed off by the clinical scientist or head of service under our quality system before go-live, and it becomes part of the evidence for ISO 15189 accreditation.

 

Why this answer works

This answer gives a clear, logical structure: plan, truth set, metrics, version control, risk-based scope and sign-off. It names realistic reference resources and highlights clinically important edge cases, showing practical understanding rather than theory.

 

Key points to include

• A written plan with acceptance criteria agreed in advance
• Appropriate truth sets including reference materials and confirmed clinical samples
• Cover difficult and clinically relevant variant types
• Measure sensitivity, precision, repeatability and coverage of reportable regions
• Risk-based scope for updates plus regression testing
• Documented report and sign-off under the quality system

 

Common mistakes to avoid

• Setting acceptance criteria after seeing the results
• Validating only on easy variant types
• Not recording exact software and database versions
• Going live without formal sign-off

 

NHS values and standards

Commitment to quality of care; Everyone counts; HCPC Standards: practise safely and effectively

 

Further reading

• ISO 15189 Medical laboratories: requirements for quality and competence
• ACGS Best Practice Guidelines
• Published guidance on validation of clinical next-generation sequencing bioinformatics pipelines
• Your laboratory's validation and verification procedures

 

 

Question 8: How do you use version control and change control to make sure clinical analyses are reproducible?

Technical question  ·  Technical

 

What the interview panel is assessing

The panel is checking whether you can recreate exactly how any historic result was produced, and whether you understand the difference between developer version control and formal clinical change control. They also want to know you won't bypass process under pressure.

 

Model answer

I think of it as being able to answer one question for any report we've ever issued: exactly what produced this result? If a patient's result is questioned two years from now, we should be able to rerun it and get the same answer.

Version control is the developer side. All pipeline code lives in Git, with meaningful commit messages, branches for new work and code review through pull requests before anything is merged. Released versions are tagged, so version 2.3 always means exactly the same code. But code is only part of it. The software tools, their dependencies, the reference genome build and the annotation databases all change too. I use containers, such as Docker or Singularity, pinned to specific versions, and I record database versions so a tag captures the whole environment.

Change control is the clinical governance side, and it's separate. Just because a change is merged doesn't mean it's allowed near patient samples. Our change control process records why a change is needed, the risk assessment, what testing or validation was done, who approved it and when it went live. Only after that sign-off is the new version deployed to the production environment, which is separate from development and test.

Every sample's record then logs the pipeline version that processed it. During my STP training I helped answer a query about a two-year-old result, and because the version and container were logged, we reran it and got an identical output in an afternoon. That was the moment it clicked for me why all this matters.

The other thing I'd say is that the process has to hold even when people are in a hurry. If someone asks for a quick fix in production, I'd explain that there's usually an expedited change route for urgent safety fixes, but there's no route that skips recording and approving it.

 

Why this answer works

The answer distinguishes clearly between version control and clinical change control, and covers the full environment, not just code. The example of reproducing an old result makes it real, and the final point shows integrity under pressure.

 

Key points to include

• Every result traceable to an exact pipeline version
• Git with code review and tagged releases
• Containers and pinned versions of tools, references and databases
• Formal change control separate from merging code
• Separate development, test and production environments
• No bypassing the process, even for urgent fixes

 

Common mistakes to avoid

• Thinking Git alone is change control
• Forgetting that databases and reference files change results too
• Editing code directly in production
• Not logging the pipeline version against each sample

 

NHS values and standards

Commitment to quality of care; Working together for patients; HCPC Standards: keep accurate records

 

Further reading

• ISO 15189 requirements on control of documents and records
• Your laboratory's change control procedure
• DCB0129 and DCB0160 clinical risk management standards for health IT systems
• Software Carpentry or similar good practice in version control

 

 

Unlock 32 more NHS interview questions

You have read the free questions. The full bank adds 32 premium questions for this role, each with a model answer, what the panel is assessing, key points and common mistakes.

One-off payment of £2.99 for 12 months' access. No subscription. Use the Unlock button at the top of this page.